Source: Annual Congress 2011 - Late-Breaking Abstracts Session: New mechanisms in airway disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
T. Jolas, C. Page, L. Allegra (Celle l‘Evescault, France; London, United Kingdom; Milan, Italy). Late-breaking abstract: Further studies on the mechanism of action of doxofylline. Eur Respir J 2011; 38: Suppl. 55, 3414

Member's Comments

No comment yet.

Related content which might interest you: Late-breaking abstract: Pre-clinical efficacy of RP5090 in PI3Kδ mediated airway disorders Source: Annual Congress 2011 - Late-Breaking Abstracts Session: New treatments and targets for airway disease Year: 2011 Late-breaking abstract: The effects of roxithromycin as anti-inflammatoy agent on clinical outcomes in patient with bronchiectasis: A double blinded randomized controlled study Source: Annual Congress 2011 - Late-Breaking Abstracts Session: New treatments and targets for airway disease Year: 2011 How pharmacokinetic/pharmacodynamic science informs dosage recommendations? Source: Annual Congress 2010 - PG17 GRACE Postgraduate Course: Antimicrobial treatment of LRTI: important new aspects for clinical practice Year: 2010 Late-breaking abstract: Once-daily NVA237 improves exercise endurance from first dose in patients with COPD: The GLOW3 trial Source: Annual Congress 2011 - Late-Breaking Abstracts Session: New treatments and targets for airway disease Year: 2011 Concept and pre-clinical studies Source: Annual Congress 2010 - [italic]Ex vivo[/italic] graft evaluation and reconditionning in human lung transplantation Year: 2010 Late-breaking abstract: Local and systemic distribution of the GATA-3-specific DNAzyme hgd40 after inhalative exposure Source: Annual Congress 2011 - Late-Breaking Abstracts Session: New treatments and targets for airway disease Year: 2011 What do qualitative studies teach us about physical activity in patients with COPD? A systematic review Source: Annual Congress 2010 - Optimising the care and management of patients with COPD Year: 2010 Challenges in IPF trials: the point on endpoints Source: Annual Congress 2010 - Idiopathic pulmonary fibrosis: present understandings and future directions Year: 2010 Placebo effects in pharmaceutical clinical trials in bronchiectasis: an EMBARC study Source: Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria Year: 2020 Pragmatic controlled trial of azithromycin for asthma in adults Source: Annual Congress 2011 - Phenotyping asthma: a clue for treatments? Year: 2011 Late-breaking abstract: Sildenafil for chronic obstructive pulmonary disease: A randomized crossover trial Source: Annual Congress 2011 - COPD: integrated care and rehabilitation Year: 2011 Late Breaking Abstract - Objective physical activity as a clinical trial outcome in patients with COPD: a view on the literature from a task force of experts in the field Source: International Congress 2019 – Breathing, posture and physical activity in respiratory disease patients Year: 2019 The pre-clinical pharmacology of the inhaled muscarinic antagonist GSK573719 predicts once-daily clinical dosing Source: Annual Congress 2011 - Understanding disease and drug mechanisms Year: 2011 Late-breaking abstract: Pneumonia hospitalizations and long-term exposure to air pollution: A cohort study Source: Annual Congress 2011 - Outdoor air pollution studies Year: 2011 Late-breaking abstract: Wii Fit-step is a suitable exercise in rehabilitation programs in patients with COPD: A feasibility study Source: Annual Congress 2011 - The best abstracts in rehabilitation and chronic care 2011 (sponsored by Nutricia Advanced Medical Nutrition) Year: 2011 The EASE trial: rationale, study design and early results Source: Annual Congress 2010 - Clinical Trials: "EURO VENT - endobronchial valves in heterogeneous emphysema patients", "EASE - randomized trial of airway bypass in homogeneous emphysema" Year: 2010